Elevai Labs Inc. is implementing a 1-for-200 reverse stock split of its common stock effective November 27, 2024, meaning every 200 shares will combine into one share, with no fractional shares issued. The stock will continue trading under the symbol ELAB on The Nasdaq Capital Market after the split.